MedPath

Comparison of the Effectiveness of the Unified Protocol for Transdiagnostic Treatment and Cognitive Behavioral Therapy (CBT) in Improving Severe Health Anxiety

Not Applicable
Conditions
F45.2
illness anxiety disorder.
Hypochondriacal disorders
Registration Number
IRCT20170104031765N2
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Primary diagnosis of illness anxiety disorder according to the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5)
Diagnosis of major depressive disorder (MDD), persistent depressive disorder (PDD) based on DSM-5 criteria
Ages 18 to 65 years
Able to read and write
Not taking psychiatric drugs or in the case of taking antidepressants and anti-anxiety drugs for at least two months before the onset of interventions, the drug dose must be constant and the patient must agree to the drug dose remaining constant during the study

Exclusion Criteria

Patients with psychotic disorders
Patients with bipolar disorder
Patients with depressive disorder with psychotic symptoms
Patients with a history of drug use in the last 6 months
Patients at risk of suicide
Personality disorder making the treatment procedure very difficult
Patients with eating disorders
Having a history of incurable physical illness such as cancer
The need to change, stop or increase the drug dose or start a new drug after pre-test evaluations
Receiving other psychological treatments in the past 5 years

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Health anxiety score in Salkowski questionnaire. Timepoint: Before and after interventions and three month follow-up. Method of measurement: Health Anxiety Questionnaire - Short Form (SV-HAI).;Depression score in Beck questionnaire. Timepoint: Before and after interventions and three month follow-up. Method of measurement: Beck Depression Inventory - Second Edition (BDI-II).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath